Our impact: Ebola and Zika viral epidemics

Share it with your friends Like

Thanks! Share it with your friends!


With both Ebola and Zika grabbing headlines, viral epidemics have become a global public health focal point. The WHO has declared Ebola epidemics in both West Africa and the Congo global health emergencies, while the effects of Zika’s 2015-16 contagion are still felt today in children left with microcephaly.

We help assay developers and clinical labs respond to outbreaks like these. Our proprietary AccuPlex recombinant viral materials are safe to handle and non-infectious, yet also resemble complex clinical virus targets. This means they’re a crucial tool in developing effective solutions to combat viral outbreaks.

We’re proud to provide safe, powerful and readily-available quality control and validation materials, and of our role helping to fight infectious disease epidemics.

LGC. Science for a safer world


Write a comment